drugset / Trial / NCT03955042

Pemetrexed for the Treatment of Chordoma

NCT03955042

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the safety and tolerability of pemetrexed administered to people with chordoma. Other purposes of this study are to: * find out side effects (good and bad) of pemetrexed; * learn more about how pemetrexed might affect the growth of cancer cells; * evaluate tumor characteristics by collecting tumor tissue samples if available; * look at biomarkers (biochemical features that can be used to measure the progress of disease or the effects of a drug) in blood and cerebrospinal fluid if available.

Timeline

Start
2019-09-06
Primary completion
2022-07-27
Completion
2023-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule 900 mg/m2 Intravenous

Indications